Pediatric Epilepsy Management and Antiepileptic Drug Efficacy

Pediatric epilepsy encompasses a heterogeneous group of disorders characterised by recurrent, unprovoked seizures. Management hinges on a tailored approach that combines accurate aetiological diagnosis, seizure classification and assessment of developmental status. First-line treatment typically involves antiepileptic drugs (AEDs) selected according to seizure type and patient age, with monotherapy favoured to minimise toxicity. The choice of an AED requires careful consideration of pharmacokinetic profiles, potential neurocognitive effects and the spectrum of adverse reactions. In refractory cases, polytherapy or non-pharmacological interventions such as ketogenic diet, vagus nerve stimulation or epilepsy surgery may be required. Advances in genomic and neuroimaging techniques have illuminated syndrome-specific and aetiology-driven treatment strategies, enabling precision medicine approaches. Research is refining dosing regimens, mitigating behavioural and cognitive side effects, and expanding the therapeutic armamentarium to include novel agents targeting molecular pathways implicated in paediatric epileptogenesis. Optimising paediatric epilepsy care is globally significant for reducing seizure burden, safeguarding neurodevelopmental outcomes and improving quality of life for affected children and their families.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Pediatric Epilepsy Management and Antiepileptic Drug Efficacy publication trend

The graph below shows the total number of articles in pediatric epilepsy management and antiepileptic drug efficacy across all publications each year (not limited to Nature Index journals).

Technical terms

Antiepileptic drug (AED): Medication used to prevent or reduce the frequency of epileptic seizures.

Monotherapy: Treatment regimen employing a single AED to manage seizures.

Polytherapy: Concurrent use of two or more AEDs to control seizures in refractory cases.

Focal-onset seizure: Seizure activity originating in a specific region of the brain.

Pharmacovigilance: Systematic monitoring and assessment of drug safety and adverse reactions.

Cognitive development: Maturation of intellectual functions, including memory, attention and problem-solving.

References

1. Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study. Frontiers in Neurology (2022).
2. Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes. Acta Neurologica Belgica (2021).
3. Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study. Children (2023).